Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04935710
Other study ID # ALACRITY eSToRY R34 #1
Secondary ID P50MH126283
Status Recruiting
Phase Phase 1
First received
Last updated
Start date January 3, 2022
Est. completion date August 31, 2024

Study information

Verified date January 2024
Source Cambridge Health Alliance
Contact Margaret D Weiss, MD PhD
Phone 617-665-13338
Email madweiss@challiance.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed research project provides a novel approach to screening, early assessment, and preventive interventions for high-risk youth in racial/ethnic/linguistically (REL)-diverse communities. - The investigators assess a health promotion intervention as a way of reducing treatment disparities in REL-minority youth. This population is underrepresented in child psychiatry research. It is often excluded from clinical trials of medication or therapy because of challenges with transportation, literacy, resources, or other issues. - The study will take place during or following a healthcare crisis and economic recession, making findings relevant to understanding the mechanisms by which hardship translates into youth mental illness. - The innovative integration of online screening into school-based clinics and community-based settings in REL-minority communities is made possible by the combination of access to a new technology (CAT) in the context of a learning health community serving a REL-minority population. - Empirical research on the impact of a resilience-based prevention intervention in youth and youth at risk is both innovative and much needed during this period of health, social and economic crisis.


Description:

Four hundred high school students will be screened for psychiatric symptoms and functional impairment using the Kiddie Computerized Adaptive Testing (K-CAT) and the Weiss Functional Impairment Rating Scale - Self Report (WFIRS-S) in CHA's catchment area (Cambridge, Chelsea, Everett, Malden, Revere, Somerville, Winthrop. Students will be classified into three tiers: normal, at risk, and clinical . The cut off scores that differentiate the tiers are drawn from the ROC values generated by the psychometrics of the measures themselves as follows: - Tier 1: K-CAT Normal & WFIRS <0.8 - >1.0 (T <1SD). - Tier 2: K-CAT Mild & WFIRS 0.8 - >1.0, K-CAT Moderate & WFIRS 0.8 - 1.0 (T between 1 and 1.5 SD), K-CAT Severe & WFIRS 0.8 - 1.0 (T between 1 and 1.5 SD) - Tier 3: K-CAT Moderate & WFIRS >1.0 (T >1.5 SD), K-CAT Severe & WFIRS >1.0 (T >1.5 SD) If patients are symptomatic but not functionally impaired, status is determined by function because symptoms without impairment do not necessarily warrant intervention. If the patient is impaired but not symptomatic, the threshold is determined by symptoms because the patient may be impaired from factors other than the diagnosis. These scores are based on the results of the most severe module of either the K-CAT or the WFIRS. .All students will be eligible to participate in C2T, independent of how they are classified by Tier, unless they meet one of the exclusion criteria. Tier 3 will be informed that the participants' responses suggest that the participants are experiencing some symptoms which are causing them difficulty. As long as the participants are not assessed as critical imminent risk, Tier 3 will also be invited to participate in C2T. A stepped wedge design with 3 clusters of 36 students each will be used to group students into clusters based on rolling recruitment into COPE2Thrive. The stepped wedge design assigns a random cluster to be switched from the control group to the C2T intervention group at either one, two, or three-week intervals starting at week 1 and ending at week 23 of the study.


Recruitment information / eligibility

Status Recruiting
Enrollment 108
Est. completion date August 31, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 24 Years
Eligibility Inclusion Criteria for COPE2Thrive: - High school students in CHA's catchment area (Cambridge, Chelsea, Everett, Malden, Revere, Somerville, Winthrop) - Youth who are fluent in English, Haitian-Creole, Portuguese, or Spanish. - Youth who have completed WFIRS and K-CAT, and who do not meet the exclusion criteria. Exclusion Criteria: - 12th-graders will be excluded from the COPE2Thrive program since the participants will not be available for the study's duration. - Students who are already receiving behavioral health care. - Students who are considered to be seriously suicidal and in need of urgent care, in which case the participants would be ineligible based on the fact that the participants will be receiving behavioral health care.

Study Design


Intervention

Behavioral:
COPE2Thrive
Cognitive Behavioral Therapy-based program to help teens deal with anxiety, stress and depression by showing them how to develop skills needed to stop negative thoughts and start thinking and behaving in more positive ways.
Genetic:
Usual care
Children at risk who are not randomized to COPE2Thrive at any point of time serve as the control group.

Locations

Country Name City State
United States CHA Health Equity Research Lab Cambridge Massachusetts
United States CHA-Teen Health Center at Cambridge Rindge and Latin School Cambridge Massachusetts
United States Community Cambridge Massachusetts
United States CHA Teen Health Center at Everett High School Everett Massachusetts
United States CHA Teen Connections at Somerville High School Somerville Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Cambridge Health Alliance National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Kiddie Computerized Adaptive Testing Self Report (K-CAT-S) The K-CAT-S is a computerized adaptive test for assessment of DSM 5 conditions in youth. Adaptive testing allows the assessment to be done in less than 10 minutes with high validity compared against diagnostic interviews. High scores indicate greater psychopathology. The minimum score is 0, a score between 45-64 is moderate, a score greater than 65 is severe, and the maximum score is 100. Change in the numeric level of these symptoms will be the primary outcome of the testing of the preliminary effectiveness of the COPE2Thrive intervention. 3 months or time to completion of the COPE2T intervention
Secondary Weiss Functional Impairment Rating Scale - Self Report (WFIRS-S) The Weiss Functional Impairment Scale Self Report (WFIRS-S) is an assessment of the student's perception of the participant's functional impairment over the past month, across six domains including family, school, life skills, child's self-concept, social activities, and risky activities. Higher mean item scores indicate greater functional impairment. The minimum mean item score is 0, the maximum mean item score is 3, and the ROC population cut-off is 0.65. A mean change score of 0.25 is the minimal clinical important difference. 3 months or time to completion of the COPE2Thrive intervention
Secondary Kiddie Computerized Adaptive Testing Parent Report(K-CAT-P) The Kiddie Computerized Adaptive Testing (K-CAT-P) will be administered to parents to obtain collateral parent report of youth symptoms. The scoring metrics of this testing are identical to the Kiddie Computerized Adaptive Testing Student Report (K-CAT-S) reported above. The Kiddie Computerized Adaptive Testing Parent Report (K-CAT-P) screener provides a combined numeric score for each module based on validated quantitative comparisons. Higher scores indicate higher levels of symptoms. The minimum score for any module is 0, a numeric score between 45-64 for any module is considered moderate, a numeric score of 65 or above for any module is considered severe, and the maximum score for any module is 100.The K-CAT-P includes a total of 6 modules, so the maximum total score for the assessment is 600. 3 months or time to completion of the COPE2Thrive intervention
Secondary Weiss Functional Impairment Rating Scale - Parent Report (WFIRS-P) The Weiss Functional Impairment Scale Parent Report (WFIRS-P) is an assessment of the parent's perception of the child's functional impairment over the past month, across six domains including family, school learning and behavior, life skills, child's self-concept, social activities, and risky activities. Higher mean item scores indicate greater functional impairment. The minimum mean item score is 0, the maximum mean item score is 3, and the ROC population cut-off is 0.65. A mean change score of 0.25 is the minimal clinical important difference. 3 months or time to completion of the COPE2Thrive intervention
See also
  Status Clinical Trial Phase
Completed NCT05120167 - Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy N/A
Completed NCT01820234 - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event N/A
Completed NCT01140022 - Leveraging Technology as a Clinician Extender to Screen Culturally Diverse Young Women for Chlamydia N/A
Completed NCT04240418 - Initiative in LYon for Lung cAncer Screening Development - Prevalence Study
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Completed NCT00115557 - Delivery of Preventive Services in Primary Care N/A
Recruiting NCT05880173 - SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population N/A
Recruiting NCT05884840 - New Cardiovascular Risk Screening Strategy. N/A
Recruiting NCT05460975 - Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study)
Completed NCT02727894 - Colorectal Cancer: Screening vs. Non-Screening
Active, not recruiting NCT03861741 - A Study to Evaluate the Feasibility of Screening Relatives of Patients Affected by Non-Syndromic Thoracic Aortic Diseases N/A
Completed NCT04644874 - Geriatric Oncology Screening of Older Patients With Solid Cancers
Completed NCT01626703 - Effect of Depressin Screening and Care Program at Community Health Center N/A
Completed NCT00582829 - Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients Phase 0
Enrolling by invitation NCT04171830 - Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life N/A
Completed NCT05489978 - Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal N/A
Completed NCT04684316 - Economic Evaluation of Periodic Occupational Health Screening N/A
Completed NCT01427829 - Computer-assisted Psychosocial Risk Assessment (CaPRA) for Refugee Health and Settlement N/A
Recruiting NCT04221854 - Stool-based SDC2 DNA Methylation Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer N/A
Active, not recruiting NCT02849041 - Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells N/A